<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03504839</url>
  </required_header>
  <id_info>
    <org_study_id>2017H00451</org_study_id>
    <nct_id>NCT03504839</nct_id>
  </id_info>
  <brief_title>Same Day Subcutaneous ICD And Send Home (DASH)</brief_title>
  <acronym>DASH</acronym>
  <official_title>Same Day Subcutaneous ICD And Send Home</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emile Daoud, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Design: Prospective, non-randomized single center study at The Ohio State University Wexner&#xD;
      Medical Center.&#xD;
&#xD;
      Purpose: The purpose of this study is to prospectively evaluate a specific analgesia protocol&#xD;
      designed to allow for same day discharge following implantation of the subcutaneous&#xD;
      implantable cardiac defibrillator (S-ICD) Enrollment: Up to 40 subjects will be enrolled.&#xD;
      Subject Population: Consecutive patients undergoing S-ICD implantation under general&#xD;
      anesthesia or monitored anesthesia care.&#xD;
&#xD;
      Endpoints: Rate of successful completion of the protocol; Procedural complications; Serial&#xD;
      assessment of patient perception of pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, nonrandomized, descriptive, single center study designed to assess the&#xD;
      rate of successful completion of the study protocol in consecutive patients undergoing S-ICD&#xD;
      implantation.&#xD;
&#xD;
      Objectives To prospectively evaluate the same day discharge protocol for patients undergoing&#xD;
      S-ICD implantation.&#xD;
&#xD;
      Primary Endpoint 1. Rate of successful completion of S-ICD implantation and discharge of the&#xD;
      patient on the same day the device is implanted using the analgesia protocol.&#xD;
&#xD;
      Secondary Endpoints&#xD;
&#xD;
        1. Procedure complication (failed implantation, infection, hematoma/bleeding, etc…) within&#xD;
           30 days of procedure.&#xD;
&#xD;
        2. Serial assessment of patient perception of pain using the graded integer pain scale of&#xD;
           1-10&#xD;
&#xD;
        3. Side effects related to medical therapy of protocol.&#xD;
&#xD;
        4. Time from beginning of recovery (defined as when the patient enters the recovery IPR&#xD;
           room) to the time of discharge from the recovery unit.&#xD;
&#xD;
        5. 30 day readmission rate after discharge following S-ICD implant&#xD;
&#xD;
        6. Number of days that oral analgesics are used post discharge.&#xD;
&#xD;
      Patients will be approached for participation in the study once they have been consented for&#xD;
      implantation of the clinically indicated S-ICD&#xD;
&#xD;
      .&#xD;
&#xD;
      Pre-procedure analgesia will be given to each patient as follows:&#xD;
&#xD;
      Acetaminophen 975 mg PO x 1 will be administered 1-2 hours prior to the procedure. and&#xD;
      Oxycodone 10 mg PO x 1 will be administered 1-2 hours prior to the procedure. Anesthesia will&#xD;
      be provided by anesthesiology team as MAC or general anesthesia. Local subcutaneous&#xD;
      anesthetic will be a 50:50 mixture of 2% lidocaine and 0.5% bupivacaine; which will result in&#xD;
      a concentration of 1% lidocaine and 0.25% bupivacaine.&#xD;
&#xD;
      Starting at ≈2 hours post procedure, the patient will then enter the &quot;Preparation for&#xD;
      Discharge&quot; phase. The modified Aldrete scoring system will be used to determine eligibility&#xD;
      for discharge home.Patients with an Aldrete score ≥ 9 will be deemed eligible for discharge&#xD;
      home.&#xD;
&#xD;
      Additional standard ambulatory discharge criteria per the OSUWMC postanesthesia care policy&#xD;
      statement will be applied by the nursing team, akin to all ambulatory surgery patients at&#xD;
      OSUWMC. If the above discharge parameters (DP) are not meet, the patient will be reassessed&#xD;
      every 30 minutes until parameters are satisfied. Once the patient satisfies the DP, the&#xD;
      patient will complete the Pain Perception Questionnaire and be assessed for ambulation,&#xD;
      eating/drinking and for understanding of post discharge instructions. The electrophysiology&#xD;
      device nursing staff will review management of the S-ICD incision, device and post discharge&#xD;
      care instructions with the patient and with the accompanying family member(s)/friend. The&#xD;
      patient will be given instructions regarding management of pain and will be provided the&#xD;
      following prescription for outpatient pain control Percocet 5mg/325 mg (1 tablet every 6&#xD;
      hours). A 2-day supply will be given.&#xD;
&#xD;
      Also, the patient will be provided a phone number to contact during business hours as well as&#xD;
      for after hours to address questions/concerns.&#xD;
&#xD;
      The electrophysiology nursing staff will contact the patient the following day and again at&#xD;
      about 3 days post discharge to administer the Pain Perception Questionnaire as well as to&#xD;
      address any patient questions. The patient will then be evaluated in the Device Clinic about&#xD;
      10 days post implantation. The Pain Perception questionnaire will be administered and&#xD;
      assessment of the incision and S-ICD will be completed. The last Pain Perception&#xD;
      questionnaire will be obtained by telephone at about 30 days post implantation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 15, 2018</start_date>
  <completion_date type="Actual">April 12, 2019</completion_date>
  <primary_completion_date type="Actual">April 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Consecutive patients consented for SICD as per standard indications for device implantation</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Successful Completion of S-ICD Implantation and Discharge of the Patient on the Same Day the Device is Implanted Using the Analgesia Protocol.</measure>
    <time_frame>within 30 days of the procedure</time_frame>
    <description>Rate of successful completion of S-ICD implantation and discharge of the patient on the same day the device is implanted using the analgesia protocol.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure Complication (Failed Implantation, Infection, Hematoma/Bleeding, Etc…) Within 30 Days of Procedure.</measure>
    <time_frame>within 30 days of the procedure</time_frame>
    <description>Procedure complication (failed implantation, infection, hematoma/bleeding, etc…) within 30 days of procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serial Assessment of Patient Perception of Pain Using the Graded Integer Pain Scale of 0-10</measure>
    <time_frame>within 30 days of the procedure</time_frame>
    <description>Serial assessment of patient perception of pain using the graded integer Numeric Pain Rating Scale (NPRS) of 0-10. This is an unidimensional measure of pain intensity in adults. Zero being no pain, 1-3 being mild pain, 4-6 being moderate pain, 7-10 being severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side Effects Related to Medical Therapy of Protocol.</measure>
    <time_frame>within 30 days of the procedure</time_frame>
    <description>Side effects related to medical therapy of protocol.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time From Beginning of Recovery (Defined as When the Patient Enters the Recovery IPR Room) to the Time of Discharge From the Recovery Unit.</measure>
    <time_frame>within 30 days of the procedure</time_frame>
    <description>Time from beginning of recovery (defined as when the patient enters the recovery IPR room) to the time of discharge from the recovery unit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 Day Readmission Rate After Discharge Following S-ICD Implant</measure>
    <time_frame>within 30 days of the procedure</time_frame>
    <description>30 day readmission rate after discharge following S-ICD implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Days That Oral Analgesics Are Used Post Discharge.</measure>
    <time_frame>within 30 days of the procedure</time_frame>
    <description>Number of days that oral analgesics are used post discharge.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Cardiomyopathies</condition>
  <condition>Cardiac Death, Sudden</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>S-ICD implantation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Subcutaneous ICD with same day discharge</intervention_name>
    <description>Receiving a SICD and discharged the same day</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient consented for implantation of S-ICD.&#xD;
&#xD;
          -  Ambulatory/outpatient patient coming to the hospital setting solely for implantation&#xD;
             of S-ICD&#xD;
&#xD;
          -  Patient agrees to participate and is able to comply with the defined study protocol,&#xD;
             including assistance for home care and transportation for the first ≈12-18 hours post&#xD;
             discharge, and compliance with the required follow up.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability or unwillingness to provide informed consent&#xD;
&#xD;
          -  Patients who, for any reason, was hospitalized or in an emergency department the day&#xD;
             prior to the S-ICD implantation, including patients transferred for S-ICD implantation&#xD;
&#xD;
          -  Patients in which the hemodynamics are dependent upon intravenous pressors infusing at&#xD;
             the time of device implantation or mechanical support, inclusive of left ventricular&#xD;
             assist device and intravenous devices (balloon pump, Impella device).&#xD;
&#xD;
          -  Age &lt; 18 years.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  Currently incarcerated.&#xD;
&#xD;
          -  Hypoxia (room air oxygen &lt;91%) or acutely short of breath.&#xD;
&#xD;
          -  Hypotension (Systolic blood pressure &lt;90) unless this is patient's typical blood&#xD;
             pressure).&#xD;
&#xD;
          -  Bradycardia (heart rate &lt;45bpm, unless this is patient's typical resting heart rate).&#xD;
&#xD;
          -  Acute electrolyte disorder that cannot be easily corrected (e.g., potassium&#xD;
             supplementations) based upon Chem 6 values obtained on day of procedure.&#xD;
&#xD;
          -  Presence of a fever.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toshimasa Okabe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 4, 2018</study_first_submitted>
  <study_first_submitted_qc>April 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2018</study_first_posted>
  <results_first_submitted>February 1, 2021</results_first_submitted>
  <results_first_submitted_qc>September 22, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 23, 2021</results_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Emile Daoud, MD</investigator_full_name>
    <investigator_title>Sub-Investigator</investigator_title>
  </responsible_party>
  <keyword>defibrillator</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 6, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/39/NCT03504839/Prot_SAP_003.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 7, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/39/NCT03504839/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intervention</title>
          <description>S-ICD implantation.&#xD;
Subcutaneous ICD with same day discharge: Receiving a SICD and discharged the same day</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intervention</title>
          <description>S-ICD implantation.&#xD;
Subcutaneous ICD with same day discharge: Receiving a SICD and discharged the same day</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Rate of Successful Completion of S-ICD Implantation and Discharge of the Patient on the Same Day the Device is Implanted Using the Analgesia Protocol.</title>
        <description>Rate of successful completion of S-ICD implantation and discharge of the patient on the same day the device is implanted using the analgesia protocol.</description>
        <time_frame>within 30 days of the procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>S-ICD implantation.&#xD;
Subcutaneous ICD with same day discharge: Receiving a SICD and discharged the same day</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Successful Completion of S-ICD Implantation and Discharge of the Patient on the Same Day the Device is Implanted Using the Analgesia Protocol.</title>
          <description>Rate of successful completion of S-ICD implantation and discharge of the patient on the same day the device is implanted using the analgesia protocol.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedure Complication (Failed Implantation, Infection, Hematoma/Bleeding, Etc…) Within 30 Days of Procedure.</title>
        <description>Procedure complication (failed implantation, infection, hematoma/bleeding, etc…) within 30 days of procedure.</description>
        <time_frame>within 30 days of the procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>S-ICD implantation.&#xD;
Subcutaneous ICD with same day discharge: Receiving a SICD and discharged the same day</description>
          </group>
        </group_list>
        <measure>
          <title>Procedure Complication (Failed Implantation, Infection, Hematoma/Bleeding, Etc…) Within 30 Days of Procedure.</title>
          <description>Procedure complication (failed implantation, infection, hematoma/bleeding, etc…) within 30 days of procedure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serial Assessment of Patient Perception of Pain Using the Graded Integer Pain Scale of 0-10</title>
        <description>Serial assessment of patient perception of pain using the graded integer Numeric Pain Rating Scale (NPRS) of 0-10. This is an unidimensional measure of pain intensity in adults. Zero being no pain, 1-3 being mild pain, 4-6 being moderate pain, 7-10 being severe pain.</description>
        <time_frame>within 30 days of the procedure</time_frame>
        <population>Patient's did not always answer/call back for their follow-up phone calls.</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>S-ICD implantation.&#xD;
Subcutaneous ICD with same day discharge: Receiving a SICD and discharged the same day</description>
          </group>
        </group_list>
        <measure>
          <title>Serial Assessment of Patient Perception of Pain Using the Graded Integer Pain Scale of 0-10</title>
          <description>Serial assessment of patient perception of pain using the graded integer Numeric Pain Rating Scale (NPRS) of 0-10. This is an unidimensional measure of pain intensity in adults. Zero being no pain, 1-3 being mild pain, 4-6 being moderate pain, 7-10 being severe pain.</description>
          <population>Patient's did not always answer/call back for their follow-up phone calls.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Post-Operation Day #0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>mild pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                  </measurement_list>
                </category>
                <category>
                  <title>moderate pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>severe pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Operation Day #1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>mild pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>moderate pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>severe pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Operation Day #3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>mild pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>moderate pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>severe pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Operation Day #14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>mild pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>moderate pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>severe pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-Operation Day #30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>mild pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>moderate pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>severe pain</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Side Effects Related to Medical Therapy of Protocol.</title>
        <description>Side effects related to medical therapy of protocol.</description>
        <time_frame>within 30 days of the procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>S-ICD implantation.&#xD;
Subcutaneous ICD with same day discharge: Receiving a SICD and discharged the same day</description>
          </group>
        </group_list>
        <measure>
          <title>Side Effects Related to Medical Therapy of Protocol.</title>
          <description>Side effects related to medical therapy of protocol.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time From Beginning of Recovery (Defined as When the Patient Enters the Recovery IPR Room) to the Time of Discharge From the Recovery Unit.</title>
        <description>Time from beginning of recovery (defined as when the patient enters the recovery IPR room) to the time of discharge from the recovery unit.</description>
        <time_frame>within 30 days of the procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>S-ICD implantation.&#xD;
Subcutaneous ICD with same day discharge: Receiving a SICD and discharged the same day</description>
          </group>
        </group_list>
        <measure>
          <title>Time From Beginning of Recovery (Defined as When the Patient Enters the Recovery IPR Room) to the Time of Discharge From the Recovery Unit.</title>
          <description>Time from beginning of recovery (defined as when the patient enters the recovery IPR room) to the time of discharge from the recovery unit.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="534" spread="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>30 Day Readmission Rate After Discharge Following S-ICD Implant</title>
        <description>30 day readmission rate after discharge following S-ICD implant</description>
        <time_frame>within 30 days of the procedure</time_frame>
        <population>There were 2 unplanned healthcare visits within 30 days of implantation conclusively related to S-ICD implantation due to incisional infection successfully treated with oral antibiotics and inappropriate shocks due to oversensing, leading to S-ICD removal. Neither of these complications, however, would have been prevented even if they had stayed overnight in the hospital following outpatient S-ICD implantation.</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>S-ICD implantation.&#xD;
Subcutaneous ICD with same day discharge: Receiving a SICD and discharged the same day</description>
          </group>
        </group_list>
        <measure>
          <title>30 Day Readmission Rate After Discharge Following S-ICD Implant</title>
          <description>30 day readmission rate after discharge following S-ICD implant</description>
          <population>There were 2 unplanned healthcare visits within 30 days of implantation conclusively related to S-ICD implantation due to incisional infection successfully treated with oral antibiotics and inappropriate shocks due to oversensing, leading to S-ICD removal. Neither of these complications, however, would have been prevented even if they had stayed overnight in the hospital following outpatient S-ICD implantation.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Days That Oral Analgesics Are Used Post Discharge.</title>
        <description>Number of days that oral analgesics are used post discharge.</description>
        <time_frame>within 30 days of the procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>S-ICD implantation.&#xD;
Subcutaneous ICD with same day discharge: Receiving a SICD and discharged the same day</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Days That Oral Analgesics Are Used Post Discharge.</title>
          <description>Number of days that oral analgesics are used post discharge.</description>
          <units>days</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year, 3 months.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Intervention</title>
          <description>S-ICD implantation.&#xD;
Subcutaneous ICD with same day discharge: Receiving a SICD and discharged the same day</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Inappropriate S-ICD shocks</sub_title>
                <description>Inappropriate shocks due to oversensing, leading to S-ICD removal.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Incisional infection</sub_title>
                <description>Incisional infection successfully treated with oral antibiotics.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Research Coordinator - Adrianne Miller</name_or_title>
      <organization>The Ohio State University Medical Center</organization>
      <phone>614-688-8252</phone>
      <email>adrianne.miller3@osumc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

